https://www.selleckchem.com/pr....oducts/gsk1070916.ht
Although there was no marked difference in the final histological analysis after 3 years of therapy, patients receiving UDCA+FF had improvements or stabilization in fibrosis (85.7%), and bile duct loss (78.6%) were more than that of patients receiving UDCA (70.6% and 76.5%, respectively). Adding FF improves GLOBE and UK-PBC scores, and is also associated with the improvements or stabilization of disease features, including fibrosis and ductular injury. Adding FF improves GLOBE and UK-PBC scores, and is also associated with the improv
Like
Comment
Share
